This trial is testing a new drug to see if it is safe and effective in treating advanced solid tumors.
5 Primary · 6 Secondary · Reporting Duration: 26 months
Experimental Treatment
300 Total Participants · 10 Treatment Groups
Primary Treatment: RP1 · No Placebo Group · Phase 2
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: